GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (FRA:3D7) » Definitions » Marketable Securities

Willow Biosciences (FRA:3D7) Marketable Securities : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Willow Biosciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Willow Biosciences's Marketable Securities for the quarter that ended in Sep. 2024 was €0.00 Mil.

Willow Biosciences's annual Marketable Securities increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€2.79 Mil) but then declined from Dec. 2022 (€2.79 Mil) to Dec. 2023 (€0.01 Mil).

Willow Biosciences Marketable Securities Historical Data

The historical data trend for Willow Biosciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Marketable Securities Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 - - 2.79 0.01

Willow Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 0.01 0.01 -

Willow Biosciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Willow Biosciences  (FRA:3D7) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Willow Biosciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (FRA:3D7) » Definitions » Marketable Securities
Comparable Companies
XCNQ:IMCC XCNQ:OILS TSX:CTX XCNQ:MVMD NEOE:FH TSXV:PCLO TSXV:MPH XCNQ:PWR XCNQ:RIV TSXV:VM ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
CANSF:USA WLLW:Canada
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Website
https://www.willowbio.com
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

Willow Biosciences Headlines

No Headlines